BDRX Institutional Ownership & Shareholders
BIODEXA PHARMACEUTICALS-ADR (BDRX) is currently held by 6 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $9,604 based on the latest available SEC Form 13F filings for the quarter ended September 30, 2026.
Stonex Group Inc. is currently the largest disclosed institutional shareholder of BDRX tracked by InsiderSet, reporting ownership valued at approximately $8,373 in its September 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $29,997.6, representing an estimated gain of +258.27% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed BDRX value among the investors covered in this analysis. Major shareholders include Stonex Group Inc., Ubs Group Ag, Hrt Financial Lp, and several other long-term asset managers with concentrated positions in BIODEXA PHARMACEUTICALS-ADR (BDRX).
This page ranks the largest institutional BDRX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
6
Total Reported Value
$9,604
Largest Holder
Stonex Group Inc.
Largest Position
$8,373
Insider Transactions (90d)
0
Latest Filing Quarter
Q3 2026
New Institutional Positions
10
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Stonex Group Inc. | 0.00% | 12,499 | $8,373 | $29,998 | +$21,625 | +258.27% | |
| Ubs Group Ag | 0.00% | 1,786 | $1,171 | $4,286 | +$3,115 | +266.05% | |
| Hrt Financial Lp | 0.00% | 71,249 | $46 | $170,998 | +$170,952 | +371633.91% | |
| Sbi Securities Co., Ltd. | 0.00% | 19 | $12 | $46 | +$34 | +280.00% | |
| Caitong International Asset Management Co., Ltd | 0.00% | 1 | $1 | $2 | +$1 | +140.00% | |
| Jpmorgan Chase & Co | 0.00% | 1 | $1 | $2 | +$1 | +140.00% |
Frequently asked questions about BDRX
Who are the largest institutional holders of BDRX?
The largest institutional holders of BDRX reported in the latest SEC Form 13F filings include Stonex Group Inc., Ubs Group Ag, Hrt Financial Lp, Sbi Securities Co., Ltd., and Caitong International Asset Management Co., Ltd. InsiderSet ranks institutional holders by their latest reported BDRX position.
What is BDRX institutional ownership?
This page tracks BDRX positions reported by institutional investment managers through SEC Form 13F. BIODEXA PHARMACEUTICALS-ADR (BDRX) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.
How many institutions own BDRX?
InsiderSet currently tracks 6 institutional managers reporting BDRX holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of BDRX shareholders.
How much BDRX stock do institutions own?
Institutional investment managers disclosed approximately $9,604 in BDRX holdings for Q3 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.
When was BDRX institutional ownership last updated?
The latest BDRX institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended September 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.
Are institutional BDRX holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its BDRX position after the reporting date.
Are institutions buying or selling BDRX?
Institutional buying and selling can be analyzed by comparing BDRX positions across consecutive 13F reporting periods. InsiderSet's BDRX Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View BDRX ownership changes.
How has BDRX institutional ownership changed over time?
InsiderSet tracks BDRX institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.